1832 Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-60,600
Closed -$4.81M 754
2018
Q2
$4.81M Sell
60,600
-144,600
-70% -$12M 0.02% 294
2018
Q1
$18.4M Sell
205,200
-125,361
-38% -$12M 0.07% 184
2017
Q4
$34.4M Sell
330,561
-702,486
-68% -$79.3M 0.11% 148
2017
Q3
$145M Buy
1,033,047
+684,913
+197% +$93.3M 0.51% 55
2017
Q2
$45.1M Sell
348,134
-114,051
-25% -$14M 0.2% 111
2017
Q1
$56.5M Sell
462,185
-642,941
-58% -$76.9M 0.2% 111
2016
Q4
$123M Buy
1,105,126
+861,607
+354% +$96M 0.21% 114
2016
Q3
$25.2M Sell
243,519
-70,365
-22% -$7.62M 0.09% 185
2016
Q2
$30.9M Buy
313,884
+313,832
+603,523% +$32.5M 0.12% 163
2016
Q1
$5K Buy
+52
New +$5.35K ﹤0.01% 575
2015
Q4
Sell
-324,640
Closed -$35.2M 744
2015
Q3
$35.2M Buy
324,640
+101,860
+46% +$12.6M 0.15% 135
2015
Q2
$25.8M Sell
222,780
-171,620
-44% -$19.6M 0.09% 190
2015
Q1
$44.4M Sell
394,400
-805,400
-67% -$96.2M 0.17% 122
2014
Q4
$133M Buy
1,199,800
+1,196,300
+34,180% +$126M 0.41% 67
2014
Q3
$332K Sell
3,500
-461,920
-99% -$41.7M ﹤0.01% 463
2014
Q2
$39.9M Buy
465,420
+460,020
+8,519% +$35M 0.13% 169
2014
Q1
$377K Sell
5,400
-943,200
-99% -$74.7M ﹤0.01% 473
2013
Q4
$79.6M Sell
948,600
-27,600
-3% -$2.18M 0.31% 83
2013
Q3
$74.7M Buy
976,200
+338,800
+53% +$23.7M 0.33% 81
2013
Q2
$36.9M Buy
+637,400
New +$38.4M 0.16% 139

Other funds holding CELG

1832 Asset Management's CELG Position: Q3 2018 in Review

1832 Asset Management sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 60,600 shares — an estimated $4.81M sold.

1832 Asset Management first reported a position in CELG in Q2 2013 and held it in 20 quarters. The position peaked at $145M in Q3 2017. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • 1832 Asset Management reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • 1832 Asset Management sold 60,600 Celgene Corp shares in Q3 2018, an estimated $4.81M.
  • 1832 Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 20 quarters.
  • 1832 Asset Management's Celgene Corp position peaked at $145M in Q3 2017.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on 1832 Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.